Sky Century Investment (SKYI) EBITDA (2024 - 2026)

Sky Century Investment's (SKYI) quarterly EBITDA came in at -$4347.0 in Q2 2026, up 66.68% year-on-year from -$2608.0 in Q2 2025, and down 173.52% on a QoQ basis from $5913.0 in Q1 2026.

Sky Century Investment (SKYI) EBITDA (2024 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 3 years of EBITDA data on file, last reported at -$4347.0 in Q2 2026.

  • On a quarterly basis, EBITDA rose 66.68% year-over-year to -$4347.0 in Q2 2026; TTM through May 2026 was -$62452.0, a 25.15% increase from a year earlier, with the FY2025 full-year figure at -$116631.0, down 59.94% from the prior year.
  • EBITDA for Q2 2026 stood at -$4347.0, down from $5913.0 in the prior quarter.
  • Over the last five years, EBITDA for SKYI reached as high as $5913.0 in Q1 2026 and fell as low as -$41115.0 in Q4 2024.
  • Historically, EBITDA has averaged -$20794.3 across 3 years, with a median of -$26406.5 in 2024.
  • Across the five-year window, EBITDA tumbled 1271.84% in 2025 and surged 122.18% in 2026, its largest moves.
  • Year by year, EBITDA stood at -$41115.0 in 2024, then jumped by 31.38% to -$28213.0 in 2025, then surged by 84.59% to -$4347.0 in 2026.
  • Per Business Quant data, the three most recent EBITDA figures were -$4347.0 in Q2 2026, $5913.0 in Q1 2026, and -$28213.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 -4,347.00

Historic Data

Download Data
DateValue
May 31, 2026 -4,347.00
Feb 28, 2026 5,913.00
Nov 30, 2025 -28,213.00
Aug 31, 2025 -35,805.00
May 31, 2025 -13,047.00
Feb 28, 2025 -26,664.00
Nov 30, 2024 -41,115.00
Aug 31, 2024 -2,610.00
May 31, 2024 -26,149.00
Feb 29, 2024 -35,906.00